K180388 is an FDA 510(k) clearance for the Transcend 365 miniCPAP System. Classified as Ventilator, Non-continuous (respirator) (product code BZD), Class II - Special Controls.
Submitted by Somnetics International, Inc. (New Brighton, US). The FDA issued a Cleared decision on November 30, 2018 after a review of 290 days - an extended review cycle.
This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5905 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.